Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Invested Capital: 2009-2025

Historic Invested Capital for Aytu Biopharma (AYTU) over the last 16 years, with Sep 2025 value amounting to $38.0 million.

  • Aytu Biopharma's Invested Capital rose 11.58% to $38.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.0 million, marking a year-over-year increase of 11.58%. This contributed to the annual value of $28.0 million for FY2025, which is 6.91% down from last year.
  • Aytu Biopharma's Invested Capital amounted to $38.0 million in Q3 2025, which was up 35.73% from $28.0 million recorded in Q2 2025.
  • In the past 5 years, Aytu Biopharma's Invested Capital registered a high of $153.8 million during Q2 2021, and its lowest value of $28.0 million during Q2 2025.
  • Its 3-year average for Invested Capital is $39.4 million, with a median of $38.0 million in 2025.
  • Per our database at Business Quant, Aytu Biopharma's Invested Capital soared by 61.58% in 2021 and then slumped by 61.45% in 2022.
  • Quarterly analysis of 5 years shows Aytu Biopharma's Invested Capital stood at $121.8 million in 2021, then crashed by 50.06% to $60.8 million in 2022, then plummeted by 44.29% to $33.9 million in 2023, then climbed by 2.65% to $34.8 million in 2024, then grew by 11.58% to $38.0 million in 2025.
  • Its last three reported values are $38.0 million in Q3 2025, $28.0 million for Q2 2025, and $44.9 million during Q1 2025.